Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [18F]FEPPA
- PMID: 27609240
- PMCID: PMC5342628
- DOI: 10.1176/appi.ajp.2016.16020171
Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [18F]FEPPA
Abstract
Objective: Neuroinflammation and abnormal immune responses are increasingly implicated in the pathophysiology of schizophrenia. Previous positron emission tomography (PET) studies targeting the translocator protein 18 kDa (TSPO) have been limited by high nonspecific binding of the first-generation radioligand, low-resolution scanners, small sample sizes, and psychotic patients being on antipsychotics or not being in the first episode of their illness. The present study uses the novel second-generation TSPO PET radioligand [18F]FEPPA to evaluate whether microglial activation is elevated in the dorsolateral prefrontal cortex and hippocampus of untreated patients with first-episode psychosis.
Method: Nineteen untreated patients with first-episode psychosis (14 of them antipsychotic naive) and 20 healthy volunteers underwent a high-resolution [18F]FEPPA PET scan and MRI. Dynamic PET data were analyzed using the validated two-tissue compartment model with arterial plasma input function with total volume of distribution (VT) as outcome measure. All analyses were corrected for TSPO rs6971 polymorphism (which is implicated in differential binding affinity).
Results: No significant differences were observed between patients and healthy volunteers in microglial activation, as indexed by [18F]FEPPA VT, in either the dorsolateral prefrontal cortex or the hippocampus. There were no significant correlations between [18F]FEPPA VT and duration of illness, clinical presentation, or neuropsychological measures after adjusting for multiple testing.
Conclusions: The lack of significant differences in [18F]FEPPA VT between groups suggests that microglial activation is not present in first-episode psychosis.
Keywords: Imaging; Microglia; Neuroinflammation; PET; Psychosis; Schizophrenia.
Figures
![FIGURE 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5342628/bin/nihms846569f1.gif)
![FIGURE 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5342628/bin/nihms846569f2.gif)
Similar articles
-
Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies.Psychol Med. 2019 Oct;49(13):2186-2196. doi: 10.1017/S0033291718003057. Epub 2018 Oct 25. Psychol Med. 2019. PMID: 30355368 Free PMC article. Review.
-
Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [18F]FEPPA.Neuropsychopharmacology. 2017 Dec;42(13):2474-2481. doi: 10.1038/npp.2017.111. Epub 2017 Jun 12. Neuropsychopharmacology. 2017. PMID: 28604733 Free PMC article.
-
The methodology of TSPO imaging with positron emission tomography.Biochem Soc Trans. 2015 Aug;43(4):586-92. doi: 10.1042/BST20150058. Epub 2015 Aug 3. Biochem Soc Trans. 2015. PMID: 26551697 Free PMC article. Review.
-
Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.Schizophr Bull. 2015 Jan;41(1):85-93. doi: 10.1093/schbul/sbu157. Epub 2014 Nov 9. Schizophr Bull. 2015. PMID: 25385788 Free PMC article.
-
Neuroinflammation in healthy aging: a PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [(18)F]-FEPPA.Neuroimage. 2014 Jan 1;84:868-75. doi: 10.1016/j.neuroimage.2013.09.021. Epub 2013 Sep 21. Neuroimage. 2014. PMID: 24064066 Free PMC article.
Cited by
-
Microglia-neuron interactions in schizophrenia.Front Cell Neurosci. 2024 Mar 6;18:1345349. doi: 10.3389/fncel.2024.1345349. eCollection 2024. Front Cell Neurosci. 2024. PMID: 38510107 Free PMC article. Review.
-
Neurofilament light-chain (NfL) and 18 kDa translocator protein in early psychosis and its putative high-risk.Brain Behav Immun Health. 2024 Feb 24;37:100742. doi: 10.1016/j.bbih.2024.100742. eCollection 2024 May. Brain Behav Immun Health. 2024. PMID: 38495956 Free PMC article.
-
Immune System and Brain/Intestinal Barrier Functions in Psychiatric Diseases: Is Sphingosine-1-Phosphate at the Helm?Int J Mol Sci. 2023 Aug 10;24(16):12634. doi: 10.3390/ijms241612634. Int J Mol Sci. 2023. PMID: 37628815 Free PMC article. Review.
-
Microglia and Other Cellular Mediators of Immunological Dysfunction in Schizophrenia: A Narrative Synthesis of Clinical Findings.Cells. 2023 Aug 19;12(16):2099. doi: 10.3390/cells12162099. Cells. 2023. PMID: 37626909 Free PMC article. Review.
-
Microglia and cognitive impairment in schizophrenia: translating scientific progress into novel therapeutic interventions.Schizophrenia (Heidelb). 2023 Jul 10;9(1):42. doi: 10.1038/s41537-023-00370-z. Schizophrenia (Heidelb). 2023. PMID: 37429882 Free PMC article. Review.
References
-
- Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996;19:312–318. - PubMed
-
- Gehrmann J, Matsumoto Y, Kreutzberg GW. Microglia: intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev. 1995;20:269–287. - PubMed
-
- Burguillos MA, Deierborg T, Kavanagh E, et al. Caspase signalling controls microglia activation and neurotoxicity. Nature. 2011;472:319–324. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical